Home HKUMed identifies PLK4 as a promising therapeutic target for TP53 mutated AML, demonstrated in Queen Mary Hospital and other studies bykhoinguyenvn27@gmail.com —January 03, 2024 0 HKUMed identifies PLK4 as a promising therapeutic target for TP53 mutated AML, demonstrated in Queen Mary Hospital and other studies * This article was originally published here
Post a Comment